Skip to main content
SpringerLink
Log in

Prospective Analysis of Accuracy of Positron Emission Tomography, Computed Tomography, and Endoscopic Ultrasonography in Staging of Adenocarcinoma of the Esophagus and the Esophagogastric Junction

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Exact preoperative staging of esophageal cancer is essential for accurate prognosis and selection of appropriate treatment modalities.

Methods: Forty-two patients with adenocarcinoma of the esophagus or the esophagogastric junction suitable for radical esophageal resection were staged with positron emission tomography (PET), spiral computed tomography (CT), and endoscopic ultrasonography (EUS).

Results: Diagnostic sensitivity for the primary tumor was 83% for PET and 67% for CT; for local peritumoral lymph node metastasis, it was 37% for PET and 89% for EUS; and for distant metastasis, it was 47% for PET and 33% for CT. Diagnostic specificity for local lymph node metastasis was 100% with PET and 54% with EUS, and for distant metastasis, it was 89% for PET and 96% for CT. Accuracy for locoregional lymph node metastasis was 63% for PET, 66% for CT, and 75% for EUS, and for distant metastasis, it was 74% with PET and 74% with CT. Of the 10 patients who were considered inoperable during surgery, PET identified 7 and CT 4. The false-negative diagnoses of stage IV disease in PET were peritoneal carcinomatosis in two patients, abdominal para-aortic cancer growth in one, metastatic lymph nodes by the celiac artery in four, and metastases in the pancreas in one. PET showed false-positive lymph nodes at the jugulum in three patients.

Conclusions: The diagnostic value of PET in the staging of adenocarcinoma of the esophagus and the esophagogastric junction is limited because of low accuracy in staging of paratumoral and distant lymph nodes. PET does, however, seem to detect organ metastases better than CT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510–3.

    Article  CAS  PubMed  Google Scholar 

  2. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049–53.

    Article  CAS  PubMed  Google Scholar 

  3. Sihvo EI, Salminen JT, Rämö OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol 2000;35:1082–6.

    Article  CAS  PubMed  Google Scholar 

  4. Masurin VS, Ryndin VD, Efimov ON, Allahverdjian AS. Surgery of localized cardioesophageal cancer. Semin Surg Oncol 1992;8:33–6.

    CAS  PubMed  Google Scholar 

  5. Rahamim J, Cham CW. Oesophagogastrectomy for carcinoma of the oesophagus and cardia. Br J Surg 1993;80:1305–9.

    Article  CAS  PubMed  Google Scholar 

  6. Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 1996;111:85–94, discussion 94–5.

    Article  CAS  PubMed  Google Scholar 

  7. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360–7, discussion 368–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Ajani JA, Komaki R, Putnam JB, et al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 2001;92:279–86.

    Article  CAS  PubMed  Google Scholar 

  9. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–7.

    Article  CAS  PubMed  Google Scholar 

  10. Lew JI, Gooding WE, Ribeiro U Jr, Safatle-Ribeiro AV, Posner MC. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg 2001;136:737–42, discussion 743.

    Article  CAS  PubMed  Google Scholar 

  11. Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 2000;232:733–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001;49:534–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Richards DG, Brown TH, Manson JM. Endoscopic ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction. Ann R Coll Surg Engl 2000;82:311–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  14. Vickers J. Role of endoscopic ultrasound in the preoperative assessment of patients with oesophageal cancer. Ann R Coll Surg Engl 1998;80:233–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Salminen JT, Färkkila MA, Rämö OJ, et al. Endoscopic ultrasonography in the preoperative staging of adenocarcinoma of the distal oesophagus and oesophagogastric junction. Scand J Gastroenterol 1999;34:1178–82.

    Article  CAS  PubMed  Google Scholar 

  16. Maerz LL, Deveney CW, Lopez RR, McConnell DB. Role of computed tomographic scans in the staging of esophageal and proximal gastric malignancies. Am J Surg 1993;165:558–60.

    Article  CAS  PubMed  Google Scholar 

  17. Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology 1991;181:426–32.

    Article  CAS  PubMed  Google Scholar 

  18. Reed CE, Mishra G, Sahai AV, Hoffman BJ, Hawes RH. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999;67:319–21, discussion 322.

    Article  CAS  PubMed  Google Scholar 

  19. Collard JM. Role of videoassisted surgery in the treatment of oesophageal cancer. Ann Chir Gynaecol 1995;84:209–14.

    CAS  PubMed  Google Scholar 

  20. Luketich JD, Schauer P, Urso K, et al. Minimally invasive surgical biopsy confirms PET findings in esophageal cancer. Surg Endosc 1997;11:1213–5.

    Article  CAS  PubMed  Google Scholar 

  21. Romijn MG, van Overhagen H, Spillenaar Bilgen EJ, Ijzermans JN, Tilanus HW, Lameris JS. Laparoscopy and laparoscopic ultrasonography in staging of oesophageal and cardial carcinoma. Br J Surg 1998;85:1010–2.

    Article  CAS  PubMed  Google Scholar 

  22. Pauwels EK, McCready VR, Stoot JH, van Deurzen DF. The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 1998;25:277–305.

    Article  CAS  PubMed  Google Scholar 

  23. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623–48, discussion 649–50.

    CAS  PubMed  Google Scholar 

  24. Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997;168:417–24.

    Article  CAS  PubMed  Google Scholar 

  25. Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998;78:521–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. McAteer D, Wallis F, Couper G, et al. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol 1999;72:525–9.

    Article  CAS  PubMed  Google Scholar 

  27. Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 2001;71:290–4.

    Article  CAS  PubMed  Google Scholar 

  28. Rankin SC, Taylor H, Cook GJ, Mason R. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 1998;53:659–65.

    Article  CAS  PubMed  Google Scholar 

  29. Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999;86:1638–48.

    Article  CAS  PubMed  Google Scholar 

  30. Lerut T, Flamen P, Ectors N, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000;232:743–52.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. LH Sobin C Wittekind (Eds) (1997) TNM Classification of Malignant Tumors. EditionNumber5th ed. Wiley; New York: 54–58

    Google Scholar 

  32. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235–8.

    CAS  PubMed  Google Scholar 

  33. JL Fleiss (Eds) (1981) Statistical Methods for Rates and Proportions EditionNumber2nd ed. Wiley New York:

    Google Scholar 

  34. Dwyer AJ. Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology 1991;178:328–30.

    Article  CAS  PubMed  Google Scholar 

  35. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 2000;118:670–7.

    Article  CAS  PubMed  Google Scholar 

  36. Lonneux M, Borbath I, Bol A, et al. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur J Nucl Med 1999;26:591–8.

    Article  CAS  PubMed  Google Scholar 

  37. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202–10.

    Article  CAS  PubMed  Google Scholar 

  38. Vickers J, Alderson D. Influence of luminal obstruction on oesophageal cancer staging using endoscopic ultrasonography. Br J Surg 1998;85:999–1001.

    Article  CAS  PubMed  Google Scholar 

  39. Luketich JD, Schauer P, Landreneau R, et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 1997;114:817–21, discussion 821–3.

    Article  CAS  PubMed  Google Scholar 

  40. Luketich JD, Friedman DM, Weigel TL, et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999;68:1133–6, discussion 1136–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Thoracic and Esophageal Surgery, Department of Cardiothoracic Surgery, Helsinki University Central Hospital, Helsinki, Finland

    Jari V. Räsänen MD, Eero I. T. Sihvo MD & Jarmo A. Salo MD, PhD

  2. Department of Oncology and Radiotherapy, Turku PET Center, University of Turku, Turku, Finland

    M. Juhani Knuuti MD, PhD, Heikki R. I. Minn MD, PhD & Tapio Viljanen MSc

  3. Department of Surgery, Paijat-Hame Central Hospital, Lahti, Finland

    Markku E. S. Luostarinen MD, PhD

  4. School of Public Health, University of Tampere and Research Unit, Tampere University Hospital, Tampere, Finland

    Pekka Laippala PhD

  5. Division of General Thoracic and Esophageal Surgery, Department of Cardiothoracic Surgery, Helsinki University Central Hospital, PO Box 340, Haartmaninkatu 4, FIN-00029 HUS, Helsinki, Finland

    Jarmo A. Salo MD, PhD

Authors
  1. Jari V. Räsänen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eero I. T. Sihvo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Juhani Knuuti MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heikki R. I. Minn MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Markku E. S. Luostarinen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pekka Laippala PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tapio Viljanen MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jarmo A. Salo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jarmo A. Salo MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Räsänen, J.V., Sihvo, E.I.T., Knuuti, M.J. et al. Prospective Analysis of Accuracy of Positron Emission Tomography, Computed Tomography, and Endoscopic Ultrasonography in Staging of Adenocarcinoma of the Esophagus and the Esophagogastric Junction. Ann Surg Oncol 10, 954–960 (2003). https://doi.org/10.1245/ASO.2003.12.002

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.12.002

Key Words

Search

Navigation